Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrest Nicholson Regulatory News (CRST)

Share Price Information for Crest Nicholson (CRST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 236.60
Bid: 235.60
Ask: 236.00
Change: 1.60 (0.68%)
Spread: 0.40 (0.17%)
Open: 234.20
High: 237.20
Low: 233.20
Prev. Close: 235.00
CRST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

COVID-19 Update

19 Mar 2020 07:00

RNS Number : 7187G
Crest Nicholson Holdings PLC
19 March 2020
 

The information contained in this announcement is deemed by the Company to constitute inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014

 

Crest Nicholson Holdings plc

(the "Company" or "Crest Nicholson")

 

COVID-19 Update

 

Crest Nicholson today issues an update on the impact of COVID-19 on the business and in advance of its Annual General Meeting ("AGM") which will be held at 10.30 a.m. on Tuesday 24 March 2020 at Brooklands Hotel, Brooklands Drive, Weybridge, Surrey KT13 0SL.

Since the start of the calendar year, up to and including 16 March 2020, we have traded in-line with our expectations and have seen continued improvements in website traffic, footfall and reservations. We have also made strong progress in implementing the changes to our business model and operations that we outlined in our updated strategy at the end of January 2020.

However, the Board has carefully considered this week's rapidly evolving Government guidance in respect of COVID-19 and expects this to have a significant impact on visitor levels, production capability and trading performance over an unclear timeline. Accordingly, the Company has taken the difficult decision to cancel its final dividend of 21.8 pence per share, otherwise payable on 9 April 2020. Resolution 2 will therefore be withdrawn from next week's AGM.

In addition, the Company also announces that it is suspending all existing financial guidance until both the severity and duration of the COVID-19 impact becomes clearer.

The Board recognises that these are significant steps to take, but when faced with this unprecedented and unpredictable situation, considers it to be prudent to protect the Company's cash position and maintain a robust balance sheet. The Executive Leadership Team has also moved quickly in identifying further measures that will increase cash generation, and reduce cash outflow, enabling the business to trade through this period of prolonged uncertainty.

The Company has made arrangements to fully draw its £250m revolving credit facility, resulting in available cash of £185m. In the ordinary course of business, the Company has a strong balance sheet and has made good progress in reducing levels of capital employed in the current financial year. The Board has only considered it necessary to take such decisive action because of the anticipated impact from COVID-19.

We consider these measures to be in the best interests of all our stakeholders and will best ensure the long-term viability of the business at this time. Our number one priority will always be the health and welfare of our employees and sub-contractors and we are also taking the necessary steps to maintain that commitment.

 

For further information, please contact:

 

Crest Nicholson

Jenny Matthews, Head of Investor Relations +44 (0) 7557 842720

 

Finsbury +44 (0) 20 7251 3801

Faeth Birch

Philip Walters

 

The person responsible for arranging the release of this announcement on behalf of the Company is Kevin Maguire, General Counsel & Company Secretary.

 

19 March 2020

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRXVLLFBXLFBBE
Date   Source Headline
14th Aug 20174:25 pmRNSDirector/PDMR Shareholding
3rd Aug 20173:45 pmRNSDirector/PDMR Shareholding
3rd Aug 20173:40 pmRNSDirector/PDMR Shareholding
27th Jun 20177:00 amRNSAnalyst & Investor Day
13th Jun 20177:00 amRNSHalf-year Report
30th May 20175:08 pmRNSHolding(s) in Company
25th May 20172:47 pmRNSDirector Declaration
16th May 20177:00 amRNSTrading Update
28th Apr 20173:24 pmRNSTotal Voting Rights
25th Apr 20171:53 pmRNSDirectorate Change
24th Apr 20174:03 pmRNSDirector/PDMR Shareholding
18th Apr 201710:52 amRNSBlock listing Interim Review
11th Apr 20173:54 pmRNSDirector/PDMR Shareholding
6th Apr 201711:45 amRNSDirector/PDMR Shareholding
30th Mar 20179:41 amRNSDirector/PDMR Shareholding
23rd Mar 20172:12 pmRNSResult of AGM
23rd Mar 20177:00 amRNSAGM Statement
9th Mar 20174:44 pmRNSDirector/PDMR Shareholding
9th Mar 20174:39 pmRNSDirector/PDMR Shareholding
6th Mar 201710:10 amRNSDirector Declaration
3rd Mar 20174:27 pmRNSHolding(s) in Company - Replacement
3rd Mar 20174:00 pmRNSTotal Voting Rights
3rd Mar 20179:49 amRNSDirector/PDMR Shareholding
28th Feb 20176:02 pmRNSTotal Voting Rights
23rd Feb 20174:26 pmRNSDirector/PDMR Shareholding
20th Feb 20176:12 pmRNSHolding(s) in Company
17th Feb 20176:04 pmRNSHolding(s) in Company
13th Feb 201712:08 pmRNSDirectorate Change
13th Feb 201711:59 amRNSAnnual Financial Report
8th Feb 20174:42 pmRNSDirector/PDMR Shareholding
1st Feb 20177:00 amRNSAdditional Listing
24th Jan 20177:00 amRNSFinal Results
10th Jan 20172:57 pmRNSDirectorate Change
6th Jan 20174:09 pmRNSHolding(s) in Company
3rd Jan 20177:00 amRNSTotal Voting Rights
30th Nov 20165:13 pmRNSTotal Voting Rights
28th Nov 20167:00 amRNSHolding(s) in Company
16th Nov 20163:49 pmRNSHolding(s) in Company
15th Nov 20167:00 amRNSTrading Statement
31st Oct 20164:54 pmRNSTotal Voting Rights
24th Oct 20166:17 pmRNSHolding(s) in Company
21st Oct 20163:18 pmRNSHolding(s) in Company
19th Oct 20162:20 pmRNSHolding(s) in Company
17th Oct 20162:35 pmRNSBlock listing Interim Review
17th Oct 20162:28 pmRNSHolding(s) in Company
14th Oct 20164:27 pmRNSHolding(s) in Company
30th Sep 20164:02 pmRNSTotal Voting Rights
22nd Sep 20162:31 pmRNSDirector/PDMR Shareholding
22nd Sep 20162:29 pmRNSDirector/PDMR Shareholding
15th Sep 20168:58 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.